Fatty Liver

A Personalized Approach to Reversing a Common, Often Silent Condition

Fatty liver disease, now more precisely termed metabolic dysfunction-associated steatotic liver disease (MASLD), has become one of the most common liver conditions worldwide, closely linked to obesity, insulin resistance and metabolic syndrome. In its early stages, it typically causes no symptoms at all, which is exactly why it is so often picked up incidentally, on a scan or blood test done for another reason.

The encouraging part of this diagnosis is that fatty liver disease exists on a spectrum, and much of that spectrum is genuinely reversible. Simple fat accumulation alone rarely causes serious harm, but for a proportion of patients, it progresses to inflammation (steatohepatitis, or MASH) and eventually fibrosis or cirrhosis. Identifying where a patient sits on this spectrum, and intervening at the right point, is what determines long-term outcome.

At the practice of Dr. Ashok Choudhury, fatty liver disease is approached as a genuinely manageable, often reversible condition, with a clear, structured plan built around each patient’s specific stage and metabolic profile.

Fatty Liver Disease Sits on a Spectrum — and Most of It Is Reversible

Understanding where you are on that spectrum shapes everything else

A fatty liver diagnosis can sound alarming, but for most patients, especially those caught early, it responds well to a clear, structured plan.

The next step is to understand:

• Whether you have simple fatty liver or the more advanced inflammatory form (MASH)
• How much, if any, fibrosis or scarring has developed
• What metabolic factors — weight, blood sugar, cholesterol — are driving the condition
• What realistic, achievable lifestyle changes can meaningfully improve your liver
• Whether medication has a role in your specific case
• What monitoring schedule is right for your stage of disease

The goal is to identify exactly where you sit on the spectrum, and act early enough that reversal, not just management, is genuinely possible.

Our Approach to Fatty Liver

1. Confirm the Diagnosis and Stage It Accurately

Not all fatty liver is the same, and accurate staging shapes the entire treatment plan.

Confirming the diagnosis Imaging, such as ultrasound, and blood tests are used to confirm fat accumulation in the liver and rule out other causes.

Distinguishing simple steatosis from MASH Assessing whether inflammation is present, alongside fat, is central to understanding risk of progression.

Assessing fibrosis non-invasively Elastography and blood-based fibrosis scores are used wherever possible to estimate scarring without the need for biopsy.

Considering biopsy when needed In select cases where non-invasive testing leaves genuine uncertainty, a liver biopsy provides the clearest answer.

2. Identify and Address Metabolic Drivers

Because fatty liver disease is fundamentally a metabolic condition, addressing its drivers is central to treatment.

Assessing weight and body composition Excess weight, particularly around the abdomen, is a key driver and a key target for treatment.

Screening for insulin resistance and diabetes Blood sugar and insulin resistance are assessed, since these are closely intertwined with fatty liver disease.

Reviewing cholesterol and triglycerides Lipid profile is assessed and managed, since it both reflects and contributes to metabolic liver disease.

Considering other contributing factors Alcohol intake, certain medications, and other conditions are reviewed to make sure no additional contributing factor is missed.

3. Build a Structured, Achievable Treatment Plan

Treatment centres on sustainable lifestyle change, supported by medication where appropriate.

Personalised dietary guidance Practical, sustainable dietary changes are recommended, tailored to individual preferences and circumstances rather than generic advice.

Structured physical activity A realistic activity plan is built around individual fitness level and lifestyle, since even modest, consistent activity meaningfully improves liver fat.

Weight loss targets Specific, evidence-based weight loss targets are set, since even modest weight loss can significantly reduce liver fat and inflammation.

Medication where appropriate For select patients, particularly those with more advanced disease, medication options are discussed as part of a broader treatment plan.

4. Monitor Progress and Prevent Advancement

Ongoing monitoring confirms whether treatment is working and catches any progression early.

Regular reassessment Blood tests and, where appropriate, repeat imaging or elastography track how the liver is responding over time.

Adjusting the plan as needed Where progress is slower than expected, the treatment plan is reviewed and adjusted accordingly.

Cardiovascular risk management Because fatty liver disease shares risk factors with heart disease, cardiovascular risk is considered as part of overall care.

Long-term follow-up A structured, ongoing follow-up schedule is maintained, since fatty liver disease requires sustained attention rather than a one-time fix.

Why Early, Structured Action Matters

Fatty liver disease rarely announces itself with symptoms until it is well advanced, which makes proactive diagnosis and early intervention so valuable. Caught early, and managed with a clear, structured plan, much of the damage associated with this condition can be meaningfully slowed or even reversed.

A Personalized Plan, Not a One-Size-Fits-All Answer

Your stage of fatty liver disease, your metabolic profile, and the lifestyle changes that will genuinely work for you are all individual. At the practice of Dr. Ashok Choudhury, your treatment plan is built specifically around your situation, not a generic template.

If you have been told you have fatty liver, or want a clearer picture of your liver health, a consultation is the right place to start.